Altimmune (ALT) Debt to Equity (2009 - 2025)
Altimmune (ALT) debt to equity from Dec 31, 2009 to Dec 31, 2025. The current Altimmune (ALT) debt to equity is 15.25%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Altimmune (ALT)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 15.25% | N/A |
| 2024 | 0.00% | N/A |
| 2023 | 0.00% | -100.00% |
| 2022 | 2.47% | +239.47% |
| 2021 | 0.73% | -10.13% |
| 2020 | 0.81% | -80.17% |
| 2019 | 4.09% | +6.70% |
| 2018 | 3.83% | +151.47% |
| 2017 | 1.52% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | 4.11% | -82.58% |
| 2013 | 23.57% | +12.27% |
| 2012 | 20.99% | N/A |
| 2011 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2009 | 0.00% | N/A |
Comparison Altimmune (ALT) debt to equity with competitors
Altimmune (ALT) debt to equity is 15.25%.